Clinical Trial Update: Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of thymosin beta-4 ophthalmic solution for dry eye. Results have been posted following completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Thymosin Beta-4 Ophthalmic Solution (thymosin beta-4)

Snippet

Sponsor: ReGenTree, LLC | Conditions: Dry Eye Syndrome, Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2012-12-24